Home › Leukoencephalopathies › NCT03624374
Natural History Study of Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL)
RecruitingObservational study
Characterization of the Natural History of Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Confirmed DARS2 mutation through genetic analysis 2. Ability of the caregiver or participant to speak and understand English at an 8th-grade level Exclusion Criteria: * The vulnerable populations of prisoners, non-viable neonates, pregnant women, adults lacking the capacity to consent, non-English speakers or children who are in foster care or wards of the state.
About the study
In this study, we will conduct retrospective chart and imaging reviews and prospective longitudinal virtual assessments of individuals with LBSL.
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · Participants: 100 · Started: Apr 1, 2018
Contact the study team
- Aditii Makwana, MS · Phone: 667-205-4498
- Jordan Goodman, MS · Phone: 443-923-2769
Official record on ClinicalTrials.gov — NCT03624374
Locations in the U.S.
| Maryland | Hugo Moser Center for Leukodystrophies, Baltimore |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.